Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents)

An update on the Management and Treatment of Deep Vein Thrombosis
pp. 207-217(11)
Authors: Chattopadhyay, D.; Al Samaraee, A.; Bhattacharya, V.

The Effect of Chronic Co-Administration of Morphine and Verapamil on Isoproterenol-Induced Heart Injury
pp. 218-224(7)
Authors: Joukar, Siyavash; Najafipour, Hamid; Dabiri, Shahriar; Sheibani, Vahid; Esmaeili-Mahani, Saeid; Ghotbi, Payam; Amanallahi, Foad; Joukar, Farzin

Diabetic Cardiomyopathy and Oxidative Stress: Role of Antioxidants
pp. 225-230(6)
Authors: A. Thandavarayan, Rajarajan; V. Giridharan, Vijayasree; Watanabe, Kenichi; Konishi, Tetsuya

Drug-Drug Interactions Associated with Antiplatelet Therapy
pp. 231-240(10)
Authors: P. Dunn, Steven; E. Macaulay, Tracy

The Blockade of Renin-Angiotensin-Aldosterone System in Hemodialysis Patients to Control Hypertension and Prevent Cardiovascular Disease: Optimal Pharmacotherapy
pp. 241-246(6)
Authors: Morishita, Yoshiyuki; Kusano, Eiji

Current Approaches to Prevention of Contrast Induced Acute Kidney Injury
pp. 247-252(6)
Authors: Blandon, Jimena; Mukherjee, Debabrata

A Review of Oxidative Stress Related Genes and New Antioxidant Therapy in Diabetic Nephropathy
pp. 253-261(9)
Authors: Makuc, Jana; Petrovic, Danijel

Evaluation of a Standardized Protocol Using Lepirudin or Argatroban for Heparin-Induced Thrombocytopenia
pp. 262-268(7)
Authors: Kennedy, Kenneth; Steinke, Doug; King, Shawn; Poe, Kevin; Reeves, Jordan; Short, Marintha

Optimal Medical Therapy for Coronary Artery Disease in 2011- Perspectives from the STICH Trial
pp. 269-276(8)
Authors: F. Whayne, Thomas; P. Saha, Sibu; Quevedo, Karla; Mukherjee, Debabrata